Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 16 01:45PM ET
17.10
Dollar change
+0.21
Percentage change
1.24
%
IndexRUT P/E- EPS (ttm)-0.38 Insider Own0.80% Shs Outstand164.65M Perf Week-5.79%
Market Cap2.82B Forward P/E13.34 EPS next Y1.28 Insider Trans-6.29% Shs Float163.46M Perf Month-7.47%
Income-61.29M PEG- EPS next Q0.06 Inst Own97.02% Short Float6.85% Perf Quarter-40.93%
Sales726.44M P/S3.88 EPS this Y278.11% Inst Trans0.91% Short Ratio6.18 Perf Half Y-26.10%
Book/sh2.62 P/B6.52 EPS next Y94.46% ROA-9.17% Short Interest11.20M Perf Year-4.95%
Cash/sh2.66 P/C6.42 EPS next 5Y- ROE-14.73% 52W Range16.76 - 33.99 Perf YTD-45.38%
Dividend Est.- P/FCF169.22 EPS past 5Y28.03% ROI-12.78% 52W High-49.69% Beta0.41
Dividend TTM- Quick Ratio2.28 Sales past 5Y27.73% Gross Margin94.27% 52W Low2.00% ATR (14)0.70
Dividend Ex-Date- Current Ratio2.42 EPS Y/Y TTM71.78% Oper. Margin-10.10% RSI (14)29.35 Volatility2.87% 2.93%
Employees598 Debt/Eq0.13 Sales Y/Y TTM40.45% Profit Margin-8.44% Recom1.75 Target Price29.38
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q206.75% Payout- Rel Volume0.31 Prev Close16.89
Sales Surprise3.24% EPS Surprise-3.08% Sales Q/Q69.27% EarningsFeb 27 AMC Avg Volume1.81M Price17.10
SMA20-5.19% SMA50-21.09% SMA200-31.20% Trades Volume374,095 Change1.24%
Date Action Analyst Rating Change Price Target Change
Mar-12-24Reiterated Needham Buy $36 → $32
Mar-12-24Downgrade Mizuho Buy → Neutral $39 → $25
Jan-30-24Initiated Robert W. Baird Outperform $40
Jan-24-24Upgrade Needham Hold → Buy $37
Dec-19-23Upgrade Morgan Stanley Equal-Weight → Overweight $31 → $40
Dec-14-23Downgrade Deutsche Bank Buy → Hold $25
Dec-13-23Initiated Citigroup Buy $38
Dec-12-23Initiated Deutsche Bank Buy $25
Nov-06-23Upgrade Mizuho Neutral → Buy $20 → $35
Oct-17-23Initiated UBS Buy $33
Apr-10-24 01:28AM
Apr-02-24 04:05PM
Apr-01-24 04:05PM
Mar-28-24 11:30AM
02:00AM
01:31PM Loading…
Mar-20-24 01:31PM
Mar-15-24 04:05PM
Mar-14-24 06:49PM
Mar-13-24 04:05PM
Mar-12-24 04:08PM
03:05PM
11:06AM
09:30AM
07:43AM
Mar-11-24 04:46PM
04:13PM Loading…
04:13PM
04:05PM
Feb-29-24 09:05AM
08:44AM
Feb-28-24 04:05PM
09:12AM
Feb-27-24 05:20PM
04:56PM
04:27PM
04:05PM
Feb-22-24 08:16PM
Feb-21-24 04:05PM
Feb-20-24 10:00AM
Feb-13-24 04:05PM
Feb-08-24 01:15PM
08:48PM Loading…
Jan-30-24 08:48PM
05:00PM
Jan-26-24 05:31PM
Jan-25-24 08:42AM
Jan-19-24 04:05PM
Jan-18-24 04:05PM
Jan-12-24 05:02PM
Dec-21-23 04:05PM
Dec-18-23 04:05PM
Dec-13-23 09:24PM
04:14PM
01:41PM
Nov-30-23 09:05AM
Nov-27-23 09:05AM
Nov-21-23 11:03PM
05:00PM
Nov-17-23 09:40AM
Nov-16-23 08:42AM
Nov-14-23 04:12PM
Nov-08-23 05:24PM
Nov-04-23 01:10PM
Nov-02-23 06:51PM
04:37PM
04:05PM
Oct-31-23 04:05PM
Oct-26-23 10:02AM
Oct-23-23 09:05AM
Oct-19-23 04:05PM
Oct-18-23 05:00PM
Oct-10-23 10:49AM
09:32AM
Oct-07-23 05:01AM
Sep-30-23 10:30AM
Sep-22-23 06:23PM
Sep-19-23 04:05PM
Aug-30-23 04:05PM
Aug-28-23 06:00PM
Aug-22-23 08:30AM
Aug-19-23 10:44AM
Aug-14-23 04:05PM
Aug-04-23 12:36PM
Aug-02-23 04:26PM
04:05PM
Aug-01-23 07:30PM
Jul-25-23 11:21AM
Jul-24-23 04:05PM
Jul-21-23 09:40AM
Jul-19-23 04:04PM
Jul-15-23 08:19AM
Jul-14-23 04:04PM
11:41AM
Jul-13-23 07:11PM
04:05PM
Jun-26-23 05:00PM
Jun-13-23 04:05PM
Jun-12-23 01:24PM
Jun-08-23 11:10AM
Jun-07-23 11:30AM
05:58AM
Jun-01-23 09:04AM
May-08-23 05:25PM
04:13PM
04:05PM
09:21AM
May-05-23 04:04PM
May-02-23 09:04AM
Apr-25-23 09:04AM
Apr-20-23 09:04AM
Apr-17-23 09:04AM
Apr-11-23 09:04AM
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAVIS STEPHENCEOApr 08 '24Sale17.8726,574474,877144,267Apr 09 06:00 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERApr 08 '24Sale17.872,71648,53528,742Apr 09 06:00 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALApr 08 '24Sale17.872,56845,89038,796Apr 09 06:00 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERApr 08 '24Sale17.871,79031,98713,100Apr 09 06:00 PM
DAVIS STEPHENCEOMar 27 '24Sale17.9017,714317,081118,842Mar 27 07:58 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 27 '24Sale17.905,43497,26926,183Mar 27 07:57 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALMar 27 '24Sale17.905,14092,00636,340Mar 27 08:00 PM
DAVIS STEPHENCEOFeb 26 '24Sale24.675,577137,585101,890Feb 27 06:02 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERFeb 26 '24Sale24.6777219,04521,067Feb 27 06:13 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALFeb 26 '24Sale24.6762415,39431,432Feb 27 06:10 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERFeb 26 '24Sale24.6747411,69411,391Feb 27 06:07 PM
DAVIS STEPHENCEOJan 08 '24Sale29.963,732111,81196,521Jan 09 06:00 PM
Teehan BrendanEVP, COO, Head of CommercialJan 08 '24Sale29.9673121,90130,949Jan 09 06:00 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryJan 08 '24Sale29.9659017,67646,901Jan 09 06:00 PM
Kihara JamesPrincipal Accounting OfficerDec 15 '23Sale28.302,00056,60011,025Dec 15 07:37 PM
Schneyer Mark C.EVP, Chief Financial OfficerNov 20 '23Sale22.645,108115,64520,486Nov 21 06:00 PM
Teehan BrendanEVP, COO, Head of CommercialNov 20 '23Sale22.644,960112,29430,393Nov 21 06:00 PM
Kihara JamesPrincipal Accounting OfficerNov 20 '23Sale22.641,98544,94013,025Nov 21 06:00 PM
DAVIS STEPHENCEOOct 06 '23Sale21.9651,5631,132,32389,131Oct 06 09:59 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryOct 06 '23Sale21.9616,369359,46345,857Oct 06 10:00 PM
Kihara JamesPrincipal Accounting OfficerSep 15 '23Sale25.882,00051,76010,778Sep 19 06:31 PM
Schneyer Mark C.EVP, Chief Financial OfficerAug 21 '23Sale29.0010,000289,97015,682Aug 23 07:31 PM
DAVIS STEPHENCEOJul 14 '23Option Exercise20.77100,0002,077,000136,695Jul 18 06:00 PM
DAVIS STEPHENCEOJul 14 '23Sale30.04100,0003,004,35036,695Jul 18 06:00 PM
DAVIS STEPHENCEOJul 12 '23Sale25.0555,1041,380,44936,695Jul 13 08:27 PM
DAVIS STEPHENCEOJul 11 '23Sale25.0016,498412,45091,799Jul 13 08:27 PM
Kihara JamesPrincipal Accounting OfficerJun 15 '23Sale24.152,00048,3009,144Jun 16 04:38 PM
Brege LauraDirectorJun 12 '23Sale24.874,500111,90613,502Jun 14 05:14 PM
Schneyer Mark C.EVP, Chief Financial OfficerJun 08 '23Option Exercise0.001,893023,798Jun 12 08:48 PM
Schneyer Mark C.EVP, Chief Financial OfficerJun 08 '23Sale25.0297424,36922,824Jun 12 08:48 PM
BAKER BROS. ADVISORS LPDirectorMay 24 '23Buy25.48553,26314,096,82539,317,673May 24 05:09 PM
BAKER BROS. ADVISORS LPDirectorMay 23 '23Option Exercise17.0125,000425,25038,620,261May 24 05:09 PM
BAKER BROS. ADVISORS LPDirectorMay 23 '23Buy25.41209,0535,312,45838,811,515May 24 05:09 PM
BAKER BROS. ADVISORS LPDirectorMay 22 '23Buy24.57134,2063,297,81538,607,761May 24 05:09 PM
Schneyer Mark C.EVP, Chief Financial OfficerMay 17 '23Sale22.5015,310344,47521,905May 19 06:48 PM
Teehan BrendanEVP, COO, Head of CommercialMay 17 '23Sale22.5014,869334,55224,356May 19 06:43 PM
Kihara JamesPrincipal Accounting OfficerMay 17 '23Sale22.505,947133,80811,144May 19 06:54 PM
DAVIS STEPHENCEOMay 01 '23Sale21.187,806165,331108,297May 02 07:02 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryMay 01 '23Sale21.1891719,42225,513May 02 07:06 PM
Teehan BrendanEVP, COO, Head of CommercialMay 01 '23Sale21.1854811,6079,487May 02 07:04 PM
DAVIS STEPHENCEOApr 29 '23Option Exercise0.0015,6250116,103May 02 07:02 PM
Teehan BrendanEVP, COO, Head of CommercialApr 29 '23Option Exercise0.001,567010,035May 02 07:04 PM